- Home
- WYY vs CING Comparison
WYY vs CING Comparison
Compare WYY & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WYY
- CING
- Stock Information
- Founded
- WYY 1991
- CING 2012
- Country
- WYY United States
- CING United States
- Employees
- WYY N/A
- CING N/A
- Industry
- WYY EDP Services
- CING Biotechnology: Pharmaceutical Preparations
- Sector
- WYY Technology
- CING Health Care
- Exchange
- WYY Nasdaq
- CING Nasdaq
- Market Cap
- WYY 29.5M
- CING 26.7M
- IPO Year
- WYY 1998
- CING 2021
- Fundamental
- Price
- WYY $5.22
- CING $3.77
- Analyst Decision
- WYY Strong Buy
- CING Strong Buy
- Analyst Count
- WYY 2
- CING 4
- Target Price
- WYY $7.50
- CING $31.00
- AVG Volume (30 Days)
- WYY 113.1K
- CING 155.8K
- Earning Date
- WYY 08-14-2025
- CING 11-06-2025
- Dividend Yield
- WYY N/A
- CING N/A
- EPS Growth
- WYY N/A
- CING N/A
- EPS
- WYY N/A
- CING N/A
- Revenue
- WYY $144,421,640.00
- CING N/A
- Revenue This Year
- WYY $9.19
- CING N/A
- Revenue Next Year
- WYY $10.81
- CING N/A
- P/E Ratio
- WYY N/A
- CING N/A
- Revenue Growth
- WYY 16.25
- CING N/A
- 52 Week Low
- WYY $2.19
- CING $3.02
- 52 Week High
- WYY $6.25
- CING $7.00
- Technical
- Relative Strength Index (RSI)
- WYY 75.13
- CING 41.45
- Support Level
- WYY $4.65
- CING $3.61
- Resistance Level
- WYY $5.07
- CING $4.43
- Average True Range (ATR)
- WYY 0.33
- CING 0.27
- MACD
- WYY 0.08
- CING -0.01
- Stochastic Oscillator
- WYY 93.75
- CING 23.64
About WYY WidePoint Corporation
WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and an Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically, the company generates a majority of its revenue from the United States and the rest from Europe.
About CING Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.